KYLE SMITH: Open Payments
NPI 1184663726 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 17 payments from 5 companies in 2025. Trend: 2023 $934 · 2024 $832 · 2025 $347
Food & beverage: $347
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 6 | $137 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| Lundbeck LLC | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
Products named: REXULTI, INGREZZA, AUSTEDO XR, ABILIFY MAINTENA, COBENFY, ABILIFY ASIMTUFII.
Industry payments across MI — which companies pay providers there.
